The discovery of CENP-A, the centromere-specific histone H3 variant turns 40 years!
Grant Rowley wrote a wonderful historical piece on the cell cycle control of this fascinating piece of chromatin! Check it out.
link.springer.com/article/10.1...
29.07.2025 11:05 β π 27 π 9 π¬ 1 π 1
Epigenetics Update - Structural mechanism of H3K27 demethylation and crosstalk with heterochromatin markers
bit.ly/44H3zCZ
Robert K. McGinty (UNC Chapel Hill) reporting in Mol Cell
#Epigenetics #DNADemethylation #Chromatin
---
Discover the breakthrough at epigenometech.com
22.07.2025 08:51 β π 4 π 1 π¬ 0 π 0
Our results support a model where SUZ12-NBD interactions with RNA act as a kinetic buffer, limiting PRC2 activity and ensuring specific targeting to CpG islands. Loss of the NBD (VEFS) disrupts this equilibrium, driving widespread, non-specific H3K27me3 deposition. 13/13
23.07.2025 23:38 β π 2 π 0 π¬ 0 π 0
PRC2 complexes containing the SUZ12-NBD strongly bind diverse forms of nucleic acids, including structured RNA and double-stranded DNA, significantly inhibiting enzymatic activity. PRC2 lacking the NBD (VEFS) is resistant to nucleic acid-mediated inhibition. 12/13
23.07.2025 23:38 β π 3 π 0 π¬ 1 π 0
Domain analysis identifies a discrete nucleic acid-binding domain (NBD) within SUZ12 responsible for constraining PRC2 activity. CryoEM studies showed the NBD in close proximity to nucleic acids. Loss of this region (NEC, VEFS) causes global H3K27me3 hypermethylation. 11/13
23.07.2025 23:38 β π 3 π 0 π¬ 1 π 0
Widespread, diffuse H3K27me3 deposition induced by VEFS expression titrates canonical PRC1 away from key genomic targets. This dispersal of PRC1 disrupts Polycomb domains, resulting in transcriptional derepression and upregulation of genes normally silenced by PRC1. 10/13
23.07.2025 23:38 β π 0 π 0 π¬ 1 π 0
Expression of the VEFS truncation globally elevates H3K27me3 independently of non-core accessory subunits. This increase occurs across multiple cell types, including both K27M-mutant DMG cells and wild-type H3 cells, highlighting intrinsic SUZ12 regulatory mechanisms. 9/13
23.07.2025 23:38 β π 1 π 0 π¬ 1 π 0
In vitro and in vivo data confirm PRC2 subcomplexes collectively support K27M-DMG proliferation. Disrupting PRC2 recruitment (ncMUT, VEFS) dramatically reduces tumor growth, and remarkably, VEFS expression alone leads to 100% survival in orthotopic xenograft models. 8/13
23.07.2025 23:38 β π 0 π 0 π¬ 1 π 0
EZH2 inhibition (Tazemetostat) or disruption of PRC2 subcomplexes (shSUZ12, ncMUT, VEFS) derepresses CDKN2A, causing significant growth defects. Knockout of CDKN2A rescues DMG cells from these proliferation defects, highlighting its critical role downstream of PRC2. 7/13
23.07.2025 23:38 β π 0 π 0 π¬ 1 π 0
RNA-seq data show that disrupting PRC2 subcomplexes (ncMUT, VEFS) in DMG cells significantly derepresses genes critical for neurodevelopment. PRC2.1/2.2 complexes thus maintain silencing of developmental regulators essential for tumor cell identity. 6/13
23.07.2025 23:38 β π 0 π 0 π¬ 1 π 0
ChIP-seq analyses reveal PRC2.1 and PRC2.2 subcomplexes act collectively to recruit PRC2 to critical genomic loci in K27M DMGs. Mutants lacking these accessory subunits (ncMUT, VEFS) show severely impaired PRC2 localization at key target genes, including CDKN2A. 5/13
23.07.2025 23:38 β π 0 π 0 π¬ 1 π 0
To investigate PRC2 targeting, we disrupted PRC2 subcomplexes using SUZ12 mutants. VEFS truncation removes all accessory subunits, while the non-core mutant (ncMUT) selectively disrupts PRC2.1 and PRC2.2 subcomplexes, preserving core PRC2 integrity. 4/13
23.07.2025 23:38 β π 0 π 0 π¬ 1 π 0
Recent studies show non-core (accessory) subunits are necessary for PRC2 targeting in mammalian cells. These subunits, interacting via SUZ12, guide PRC2 precisely to CpG islands, ensuring accurate H3K27me3 deposition and gene silencing. 3/13
23.07.2025 23:38 β π 0 π 0 π¬ 1 π 0
Diffuse midline gliomas (DMGs) carrying the H3 K27M inhibitor histone exhibit global H3K27me3 reduction but retain focal enrichment at PRC2-bound CpG islands. Understanding how this residual methylation is maintained and its functional role is a critical unresolved question. 2/13
23.07.2025 23:38 β π 0 π 0 π¬ 1 π 0
We are excited to share our new preprint demonstrating that nucleic acid interactions with SUZ12 constrain PRC2 activity, establishing a kinetic buffer essential for targeted gene silencing and revealing vulnerabilities in diffuse midline gliomas.
www.biorxiv.org/content/10.1...
23.07.2025 23:38 β π 43 π 19 π¬ 1 π 0
Domain analysis identifies a discrete nucleic acid-binding domain (NBD) within the SUZ12 N-terminus responsible for constraining PRC2 activity. CryoEM studies previously showed the NBD in close proximity to nucleic acids. Loss of this region (NEC, VEFS) causes global H3K27me3 hypermethylation. 11/13
23.07.2025 23:00 β π 0 π 0 π¬ 0 π 0
Widespread, diffuse H3K27me3 deposition induced by VEFS expression titrates canonical PRC1 away from key genomic targets. This dispersal of PRC1 disrupts Polycomb domains, resulting in transcriptional derepression and upregulation of genes normally silenced by PRC1. 10/13
23.07.2025 23:00 β π 1 π 0 π¬ 1 π 0
Expression of the VEFS truncation globally elevates H3K27me3 independently of non-core accessory subunits. This substantial increase occurs across multiple cell types, including both K27M-mutant DMG cells and wild-type H3 cells, highlighting intrinsic SUZ12 regulatory mechanisms. 9/13
23.07.2025 23:00 β π 0 π 0 π¬ 1 π 0
In vitro and in vivo data confirm PRC2 subcomplexes collectively support K27M-DMG proliferation. Disrupting PRC2 recruitment (ncMUT, VEFS) dramatically reduces tumor growth, and remarkably, VEFS expression alone leads to 100% survival in orthotopic xenograft models. 8/13
23.07.2025 23:00 β π 0 π 0 π¬ 1 π 0
EZH2 inhibition (Tazemetostat) or disruption of PRC2 subcomplexes (shSUZ12, ncMUT, VEFS) derepresses CDKN2A, causing significant growth defects. Knockout of CDKN2A rescues DMG cells from these proliferation defects, highlighting its critical role downstream of PRC2. 7/13
23.07.2025 23:00 β π 0 π 0 π¬ 1 π 0
RNA-seq data show that disrupting PRC2 subcomplexes (ncMUT, VEFS) in DMG cells significantly derepresses genes critical for neurodevelopment. PRC2.1/2.2 complexes thus maintain silencing of developmental regulators essential for tumor cell identity. 6/13
23.07.2025 23:00 β π 1 π 0 π¬ 1 π 0
ChIP-seq analyses reveal PRC2.1 and PRC2.2 subcomplexes act collectively to recruit PRC2 to critical genomic loci in K27M DMGs. Mutants lacking these accessory subunits (ncMUT, VEFS) show severely impaired PRC2 localization at key target genes, including CDKN2A. 5/13
23.07.2025 23:00 β π 0 π 0 π¬ 1 π 0
To investigate PRC2 targeting, we disrupted PRC2 subcomplexes using SUZ12 mutants. VEFS truncation removes all accessory subunits, while the non-core mutant (ncMUT) selectively disrupts PRC2.1 and PRC2.2 subcomplexes, preserving core PRC2 integrity. 4/13
23.07.2025 23:00 β π 0 π 0 π¬ 1 π 0
Recent studies show non-core (accessory) subunits are necessary for PRC2 targeting in mammalian cells. These subunits, interacting via SUZ12, guide PRC2 precisely to CpG islands, ensuring accurate H3K27me3 deposition and gene silencing. 3/13
23.07.2025 23:00 β π 0 π 0 π¬ 1 π 0
Diffuse midline gliomas (DMGs) carrying the H3 K27M inhibitor histone exhibit global loss of H3K27me3 but retain focal enrichment at PRC2-bound CpG islands. Understanding how this residual H3K27me3 is maintained, and its functional significance, may reveal critical therapeutic vulnerabilities. 2/13
23.07.2025 23:00 β π 0 π 0 π¬ 1 π 0
How do chromatin remodelers use #IDRs to find TF binding partners? In our new Molecular Cell paper, we show that Ξ²-catenin is an adaptor that links SWI/SNF (cBAF) subunit ARID1A with binding partners via IDR-domain interactions.
www.cell.com/molecular-ce...
22.07.2025 18:42 β π 88 π 34 π¬ 11 π 4
Postdoc in the Cooper lab, MT
PhD in Drosophila genetics, currently interested in complex genome interactions and mechanisms of mitotic failure.
Drosophila, heterochromatin, Wolbachia, endosymbiosis, embryogenesis, chromosomes, Mitosis, Meiosis, histones
Fascinated by fungal growth & asymmetries. Institute of Biology Valrose, CNRS-Inserm-UniversitΓ© CΓ΄tΓ© dβAzur, Nice. Microscopy addict, all things cell biological
Your friendly neighborhood geneticist π±π§
Pediatric cancer epigenetics 𧬠| CCS and TFRI scholar π¨π¦ | PhDc Jabado & Garzia labs @McGill.ca
James Davies Lab, Oxford University
professor at UCSF, engineer turned cell biologist, wants to know how cells solve geometry problems
Studying cellular #stress responses, particularly #senescence and its impact on #immune response, #ageing and #cancer, #tumorigenesis at Cancer Research UK CI βͺ@cruk-ci.bsky.socialβ¬, University of Cambridge βͺ@cam.ac.ukβ¬
Website: naritalab.com
Plant Biologist π± Junior Professor of Plant Environmental Signalling & Development π§¬π¬ Studying Flooding Tolerance & Epigenetic Memory π at @biologyunifreiburg.bsky.social @uni-freiburg.de @cibss.bsky.social
www.hartman-plantlab.com
PGY1 @StanfordPath Physician Scientist Incubator Track | Postdoc
@mischellab | visiting scientist @SwantonLab | @UCL_MBPhD alum | @ForbeckForums scholar
metabophile (muh-tab-uh-fil'): a person obsessed with all things metabolism, metabolomics
Epigeneticist, Scientist & Molecular Biologist studying epigenetic cellular memory, epigenetic inheritance & mechano-epigenomic code in gliomas.
#epigenomics #epigenetics #singlecell #chromatin
https://www.linkedin.com/in/damian-toczydlowski/
Postdoc Krebs Lab @EMBL Heidelberg
Joint with Kundaje Lab @Stanford
Previously PhD Schulz Lab @MPI-MG
Geneticist, assay development
PhD at the University of Cambridge, Dept. of Biochemistry, Miska Lab | Epigenetics, Chromatin, Inheritance and Replication 𧬠| C.elegans researcher πͺ± | Python programmer π | Cambridge RNA Club Organizer | Trinity College
Postdoc in the Buenrostro Lab @ Harvard | studying the connections between epigenetics and disease
EMBO/JSPS postdoctoral fellow in the Trono lab, EPFL. Studying regulatory evolution driven by transposable elements.
Studying Transcription and Chromatin dynamics in Plants. Senior Postdoc in Caroline Deanβs Lab.
Group leader in the Hebrew University, Israel. We study fasting, liver biology and transcriptional regulation.
www.ido-goldstein-lab.com
faculty at NYU School of Medicine. We use advanced microscopy techniques to understand gene expression. Opinions my own. timotheelionnet.net
Genetics, bioinformatics, comp bio, statistics, data science, open source, open science!
Executive Director EMBL. I have an insatiable love of biology. Consultant to ONT and Cantata (Dovetail)